← All Nucana PLC filings

Nucana PLC F-1 registration statements

The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.

NASDAQ
NCNA
Nucana PLC
F-1/A: NuCana PLC Announces Offering of ADSs and Warrants to Bolster Cancer Treatment Programs
NuCana PLC plans to raise capital through a public offering of American Depositary Shares (ADSs) and warrants to advance its ProTide technology-based cancer treatment pipeline.
NASDAQ
NCNA
Nucana PLC
F-1/A: NuCana PLC Announces Offering of ADSs and Warrants to Bolster Cancer Treatment Programs
NuCana PLC plans to raise capital through an offering of American Depositary Shares (ADSs) and warrants to advance its drug discovery and development programs focused on cancer treatment.
NASDAQ
NCNA
Nucana PLC
F-1: NuCana PLC Announces Amendment to Deposit Agreement and Files for $78 Million Securities Offering
NuCana PLC amends its deposit agreement to change the ADS ratio and eliminate pre-release transactions, while also filing for a public offering of up to $78 million in ADSs and warrants.